Myeloperoxidase gene expression and cognitive functions in depression

Advances in Medical Sciences

Volumn 60, Issue 1, 2015, Pages 1-5

  Talarowska, Monika ^a   Szemraj, Janusz ^a   Gałecki, Piotr ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Cognition; Depression; Inflammation; MPO

Indexed keywords

MESSENGER RNA; MYELOPEROXIDASE; SEROTONIN ANTAGONIST; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; PEROXIDASE;

ADULT; AGED; ARTICLE; AUDITORY VERBAL LEARNING TEST; COGNITION; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PSYCHOLOGIC TEST; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE; STROOP TEST; VERBAL FLUENCY TEST; ENZYMOLOGY; GENETICS; INFLAMMATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

COGNITION; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; HUMANS; INFLAMMATION; MALE; PEROXIDASE;

EID: 84924106008     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.1016/j.advms.2014.06.001     Document Type: Article

References (31)

1. Reynolds 3rd CF, Cuijpers P, Patel V, Cohen A, Dias A, Chowdhary N, et al. Early intervention to reduce the global health and economic burden of major depression in older adults. Annu Rev Public Health 2012;33:123-35.
2. Maes M, Kubera M, Mihaylova I, Geffard M, Galecki P, Leunis JC, et al. Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: implications for the pathways to chronic depression and neuroprogression. J Affect Disord 2013;149(1-3):23-9.
3. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44-84.
4. Vaccarino V, Brennan ML, Miller AH, Bremner JD, Ritchie JC, Lindau F, et al. Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study. Biol Psychiatry 2008; 64:476-83.
5. Gałecki P, Florkowski A, Bobińska K, ͆migielski J, Bieńkiewicz M, Szemraj J. Functional polymorphism of the myeloperoxidase gene (G-463A) in depres-sive patients. Acta Neuropsychiatr 2010;5:218-22.
6. Jolivalt C, Leininger-Muller B, Drozdz R, Naskalski JW, Siest G. Apolipoprotein E is highly susceptible to oxidation by myeloperoxidase, an enzyme present in the brain. Neurosci Lett 1996;210:61-4.
7. Nauseef WM. Contributions of myeloperoxidase to proinflammatory events: more than an antimicrobial system. Int J Hematol 2001;74:125-33.
8. Hansson M, Olsson I, Nauseef WM. Biosynthesis, processing, and sorting of human myeloperoxidase. Arch Biochem Biophys 2006;445:214-24.
9. Yap YW, Whiteman M, Cheung NS. Chlorinative stress: an underappreciated mediator of neurodegeneration? Cell Signal 2007;19:219-28.
10. Winterbourn CC. Biological reactivity and biomarkers of the neutrophil oxi-dant, hypochlorous acid. Toxicology 2002;181-182:223-7.
11. Gałecki P, Gałecka E, Maes M, Chamielec M, Orzechowska A, Bobińska K, et al. The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder. J Affect Disord 2012; 138:360-6.
12. Green PS, Mendez AJ, Jacob JS, Crowley JR, Growdon W, Hyman BT, et al. Neuronal expression of myeloperoxidase is increased in Alzheimer's disease. J Neurochem 2004;9:724-33.
13. ICD-10 classification of mental & behavioural disorders. Geneva: World Health Organization; 1993.
14. Patten S. Performance of the Composite International Diagnostic Interview Short Form for major depression in community and clinical samples. Chronic Dis Can 1997;3:18-24.
15. Talarowska M, Gałecki P, Maes M, Bobińska K, Kowalczyk E. Total antioxidant status correlates with cognitive impairment in patients with recurrent de-pressive disorder. Neurochem Res 2012;37(8):1761-7.
16. Winer J, Jung CK, Shackel I, Williams PM. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for moni-toring gene expression in cardiac myocytes in vitro. Anal Biochem 1999; 270:41-9.
17. Kirkwood B, Sterne J. Essential medical statistics. 2nd ed. New York: Wiley-Blackwell; 2003.
18. Manna I, Valentino P, La Russa A, Condino F, Nisticò R, Liguori M, et al. Genetic variation in the myeloperoxidase gene and cognitive impairment in multiple sclerosis. J Negat Results Biomed 2006;5:3.
19. Pope SK, Kritchevsky SB, Ambrosone C, Yaffe K, Tylavsky F, Simonsick EM, et al. Myeloperoxidase polymorphism and cognitive decline in older adults in the Health, Aging, and Body Composition Study. Am J Epidemiol 2006;163(12): 1084-90.
20. Lefkowitz DL, Lefkowitz SS. Microglia and myeloperoxidase: a deadly part-nership in neurodegenerative disease. Free Radic Biol Med 2008;45:726-31.
21. Ekdahl CT, Bonde S, Kokaia Z, Lindvall O. Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci USA 2003;100:13632-37.
22. Haslacher H, Perkmann T, Lukas I, Barth A, Ponocny-Seliger E, Michlmayr M. et al. Myeloperoxidase levels predict executive function. Int J Sports Med. 2012;33(12):1034-8.
23. Maes M, Galecki P, Chang YS, Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharma-col Biol Psychiatry 2011;35(3):676-92.
24. Ekmekci OB, Donma O, Sardoʇan E, Yildirim N, Uysal O, Demirel H, et al. Iron, nitric oxide, and myeloperoxidase in asthmatic patients. Biochemistry 2004;69:462-7.
25. Gray E, Thomas TL, Betmouni S, Scolding N, Love S. Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis. Brain Pathol 2008;18:86-95.
26. Maki RA, Tyurin VA, Lyon RC, Hamilton RL, DeKosky ST, Kagan VE, et al. Aberrant expression of myeloperoxidase in astrocytes promotes phospholipid oxidation and memory deficits in a mouse model of Alzheimer disease. J Biol Chem 2009;284:3158-69.
27. Meuwese MC, Stroes ES, Hazen SL, Van Miert JN, Kuivenhoven JA, Schaub RG, et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 2007;50:159-65.
28. Nicholls SJ, Hazen SL. Myeloperoxidase and cardiovascular disease. Arterios-cler Thromb Vasc Biol 2005;25:1102-11.
29. Wulsin LR. Is depression a major risk factor for coronary disease? A systematic review of the epidemiologic evidence. Harv Rev Psychiatry 2004;12:79-93.
30. Galecki P, Talarowska M, Moczulski D, Bobinska K, Opuchlik K, Galecka E, et al. Working memory impairment as a common component in recurrent depres-sive disorder and certain somatic diseases. Neuro Endocrinol Lett 2013; 34(5):436-45.
31. Mehta D, Menke A, Binder EB. Gene expression studies in major depression. Curr Psychiatry Rep 2010;12:135-44.